Bioxodes has enrolled first 16 patients in trial with BIOX-101 Completing treatment of first cohort of patients will trigger interim analysis BIOX-101 is a first-in-class drug candidate, a peptide ...
which facilitates easier interaction of the peptide with the lipid interior. The titration curves of melittin (Fig. 2A) reveal that the phospholipid–PDA vesicles could detect melittin even in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback